BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 18799920)

  • 21. [A case of relapsed colon cancer successfully treated by capecitabine].
    Hashimoto T; Yokoyama M; Kimura S; Usuba O; Toyono M
    Gan To Kagaku Ryoho; 2013 Apr; 40(4):523-7. PubMed ID: 23848025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A case of metastatic breast cancer with liver metastasis effectively treated with capecitabine and vinorelbine].
    Inari H; Chiba A; Inaba M; Ino H; Fukahori M; Yoshida A
    Gan To Kagaku Ryoho; 2009 Feb; 36(2):333-5. PubMed ID: 19223759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A phase II study of second-line neoadjuvant chemotherapy with capecitabine and radiation therapy for anthracycline-resistant locally advanced breast cancer.
    Gaui MF; Amorim G; Arcuri RA; Pereira G; Moreira D; Djahjah C; Biasoli I; Spector N
    Am J Clin Oncol; 2007 Feb; 30(1):78-81. PubMed ID: 17278899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A Case of Triple Negative Breast Cancer with Successful Control of Recurrent Disease Activity for More than Ten Years].
    Yabe N; Watanuki R; Harada Y; Kondo A; Yanagisawa T; Maeda H; Kishi M; Yoshikawa T; Osumi K; Kamiya N; Sotome K; Ishii Y; Jinno H; Ikeda T; Watanabe M
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1759-1761. PubMed ID: 38303198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A case of metastatic breast carcinoma of the cervical muscles].
    Noda S; Kashiwagi S; Kawajiri H; Takashima T; Onoda N; Hirakawa K
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2405-7. PubMed ID: 24394127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase II clinical trial of capecitabine in the treatment of advanced, persistent or recurrent squamous cell carcinoma of the cervix with translational research: a gynecologic oncology group study.
    Garcia AA; Blessing JA; Darcy KM; Lenz HJ; Zhang W; Hannigan E; Moore DH
    Gynecol Oncol; 2007 Mar; 104(3):572-9. PubMed ID: 17049588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A case of metastatic pancreatic cancer which trastuzumab+capecitabine combination therapy was effective].
    Nakatsukasa K; Koyama H; Tokugawa T; Inaba S
    Gan To Kagaku Ryoho; 2012 Aug; 39(8):1243-5. PubMed ID: 22902450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Efficacy observation of accelerated hyperfractionation recourse radiotherapy plus concurrent capecitabine in the treatment of locoregional recurrent rectal cancer].
    Zhang JD; Dai Y; Yu JM; Shao ZY
    Zhonghua Yi Xue Za Zhi; 2010 Apr; 90(14):982-4. PubMed ID: 20646649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neoadjuvant docetaxel and capecitabine and the use of thymidine phosphorylase as a predictive biomarker in breast cancer.
    Layman RM; Thomas DG; Griffith KA; Smerage JB; Helvie MA; Roubidoux MA; Diehl KM; Newman LA; Sabel MS; Hayman JA; Pierce LJ; Hayes DF; Schott AF
    Clin Cancer Res; 2007 Jul; 13(14):4092-7. PubMed ID: 17634534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Two advanced/recurrent breast cancer cases effectively treated by trastuzumab/capecitabine combination therapy].
    Inoue S; Inoue M; Takahashi H; Inoue A; Kunitomo K; Fujii H
    Gan To Kagaku Ryoho; 2008 Feb; 35(2):319-22. PubMed ID: 18281774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [More effective positioning of capecitabine for advanced and metastatic breast cancer].
    Tsuyuki S; Kawaguchisakita N; Tsubota Y; Ukikusa M; Kohno Y
    Gan To Kagaku Ryoho; 2010 Apr; 37(4):649-53. PubMed ID: 20414020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase III study on efficacy of taxanes plus bevacizumab with or without capecitabine as first-line chemotherapy in metastatic breast cancer.
    Lück HJ; Lübbe K; Reinisch M; Maass N; Feisel-Schwickardi G; Tomé O; Janni W; Aydogdu M; Neunhöffer T; Ober A; Aktas B; Park-Simon TW; Schumacher C; Höffkes HG; Illmer T; Wagner H; Mehta K; von Minckwitz G; Nekljudova V; Loibl S
    Breast Cancer Res Treat; 2015 Jan; 149(1):141-9. PubMed ID: 25519041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase II trial of capecitabine and cisplatin in advanced, persistent, or recurrent carcinoma of the cervix.
    Errihani H; M'rabti H; Ismaili N; Inrhaoun H; Elghissassi I
    Int J Gynecol Cancer; 2011 Feb; 21(2):373-7. PubMed ID: 21270619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized study of orally administered fluorinated pyrimidines (capecitabine versus S-1) in women with metastatic or recurrent breast cancer: Japan Breast Cancer Research Network 05 Trial.
    Yamamoto D; Iwase S; Tsubota Y; Ariyoshi K; Kawaguchi T; Miyaji T; Sueoka N; Yamamoto C; Teramoto S; Odagiri H; Kitamura K; Nagumo Y; Yamaguchi T
    Cancer Chemother Pharmacol; 2015 Jun; 75(6):1183-9. PubMed ID: 25862350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adjuvant capecitabine, docetaxel, cyclophosphamide, and epirubicin for early breast cancer: final analysis of the randomized FinXX trial.
    Joensuu H; Kellokumpu-Lehtinen PL; Huovinen R; Jukkola-Vuorinen A; Tanner M; Kokko R; Ahlgren J; Auvinen P; Paija O; Helle L; Villman K; Nyandoto P; Nilsson G; Pajunen M; Asola R; Poikonen P; Leinonen M; Kataja V; Bono P; Lindman H
    J Clin Oncol; 2012 Jan; 30(1):11-8. PubMed ID: 22105826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A non-invasive form of lipid-secreting carcinoma of the breast.
    Nagata Y; Hanagiri T; Ono K; Shimokawa H; Yamazaki M; Takenaka M; Yamada S; Yano K; Morita M
    Breast Cancer; 2012 Jan; 19(1):83-7. PubMed ID: 21104351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Long-term response of liver metastases of breast cancer to capecitabine--case report].
    Macková D
    Klin Onkol; 2010; 23(1):46-8. PubMed ID: 20192074
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concurrent bevacizumab with a sequential regimen of doxorubicin and cyclophosphamide followed by docetaxel and capecitabine as neoadjuvant therapy for HER2- locally advanced breast cancer: a phase II trial of the NSABP Foundation Research Group.
    Rastogi P; Buyse ME; Swain SM; Jacobs SA; Robidoux A; Liepman MK; Pajon ER; Dy PA; Posada JG; Melnik MK; Piette F; Geyer CE; Mamounas EP; Wolmark N
    Clin Breast Cancer; 2011 Aug; 11(4):228-34. PubMed ID: 21684812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A patient with axillary node metastasis from breast cancer who responded to trastuzumab/capecitabine combination therapy].
    Tokugawa T; Kobayashi A; Matsuyama T; Imai S; Koyama H
    Gan To Kagaku Ryoho; 2009 Mar; 36(3):467-9. PubMed ID: 19295273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Capecitabine: expanding options for the treatment of patients with early or locally advanced breast cancer.
    Wardley A
    Oncologist; 2006; 11 Suppl 1():20-6. PubMed ID: 16971736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.